Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Provectus Biopharmaceuticals Inc PVCT

Healthcare
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform comprises a range of different drug product candidates and preclinical pharmaceutical-grade RBS formulations using different concentrations and delivered by different routes of administration specific to each disease area and/or indication. The Company’s HX medical science platform includes clinical development programs in oncology, dermatology, and ophthalmology; in vivo proof-of-concept drug discovery programs in oncology, hematology, wound healing, and animal health, and in vitro drug discovery programs in infectious diseases and tissue regeneration and repair.


OTCQB:PVCT - Post by User

Provectus Biopharmaceuticals Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by greenlegalteamon Jun 04, 2014 10:33am
345 Views
Post# 22628646

TD Ameritrade Trading Halt in PVCT

TD Ameritrade Trading Halt in PVCT
If you were a customer of TD Ameritrade and could not sell shares of PVCT on January 23, 2014, please contact us. Our law firm has been retained by more than 20 PVCT investors to attempt to recover from TD Ameritrade through the FINRA arbitration process. Our actions against TDA for halting trading are ongoing.

In addition, our firm has partnered with one of the nation's largest securities class action firms, Robbins Geller, in order to investigate Provectus and its Officers. If you would like more information on the action, please contact us.

Please contact us by phone at 1-855-462-3330.

Thank you.

The Green Firm LLC


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities